Total Payments
$444,684
2024 Payments
$70,280
Companies
63
Transactions
1,970
Medicare Patients
4,555
Medicare Billing
$368,582
Payment Breakdown by Category
Other$290,530 (65.3%)
Consulting$63,399 (14.3%)
Travel$55,332 (12.4%)
Food & Beverage$35,296 (7.9%)
Education$127.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $246,980 | 165 | 55.5% |
| Consulting Fee | $63,399 | 28 | 14.3% |
| Travel and Lodging | $55,332 | 227 | 12.4% |
| Honoraria | $43,200 | 27 | 9.7% |
| Food and Beverage | $35,296 | 1,514 | 7.9% |
| Debt forgiveness | $350.00 | 1 | 0.1% |
| Education | $127.21 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $113,331 | 242 | $0 (2024) |
| Genentech USA, Inc. | $75,356 | 140 | $0 (2022) |
| Axsome Therapeutics, Inc. | $69,272 | 113 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $54,588 | 97 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $44,873 | 167 | $0 (2023) |
| Amgen Inc. | $18,500 | 166 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $17,849 | 39 | $0 (2024) |
| ABBVIE INC. | $14,696 | 42 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $11,113 | 54 | $0 (2017) |
| Esperion Therapeutics, Inc. | $10,891 | 43 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $70,280 | 247 | Axsome Therapeutics, Inc. ($38,508) |
| 2023 | $52,303 | 207 | Axsome Therapeutics, Inc. ($30,744) |
| 2022 | $13,400 | 155 | Genentech USA, Inc. ($9,939) |
| 2021 | $34,162 | 234 | Genentech USA, Inc. ($24,255) |
| 2020 | $26,145 | 194 | Genentech USA, Inc. ($13,783) |
| 2019 | $64,260 | 278 | Genentech USA, Inc. ($27,357) |
| 2018 | $46,527 | 257 | Takeda Pharmaceuticals U.S.A., Inc. ($24,383) |
| 2017 | $137,607 | 398 | AstraZeneca Pharmaceuticals LP ($67,300) |
All Payment Transactions
1,970 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $83.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,995.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,140.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $570.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Cardio-renal | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $94.13 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $10.36 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $122.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $31.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Inflammation | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.06 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | Cash or cash equivalent | $51.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $37.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/19/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,506 | 2,711 | $378,607 | $129,216 |
| 2022 | 23 | 1,136 | 2,049 | $250,754 | $100,176 |
| 2021 | 22 | 977 | 2,417 | $124,125 | $76,529 |
| 2020 | 20 | 936 | 1,596 | $119,593 | $62,661 |
Total Patients
4,555
Total Services
8,773
Medicare Billing
$368,582
Procedure Codes
92
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 369 | $96,605 | $30,697 | 31.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 486 | $54,312 | $21,237 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 150 | 170 | $59,834 | $19,527 | 32.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 158 | 158 | $31,058 | $19,402 | 62.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 149 | 221 | $39,204 | $12,212 | 31.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $6,314 | $3,478 | 55.1% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 45 | 53 | $4,240 | $2,881 | 67.9% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2023 | 11 | 11 | $3,542 | $2,781 | 78.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 73 | 100 | $12,200 | $2,213 | 18.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $2,730 | $2,042 | 74.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 98 | 98 | $1,960 | $1,724 | 88.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 47 | 48 | $12,384 | $1,700 | 13.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 94 | 176 | $10,560 | $1,541 | 14.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 30 | 30 | $6,360 | $1,481 | 23.3% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 11 | 11 | $2,090 | $1,439 | 68.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,736 | $914.81 | 52.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 33 | 33 | $1,320 | $678.90 | 51.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $1,232 | $649.22 | 52.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 29 | 31 | $2,170 | $554.18 | 25.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 11 | 11 | $550.00 | $446.05 | 81.1% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 12 | 13 | $1,664 | $427.88 | 25.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 11 | 11 | $1,254 | $271.52 | 21.7% |
| 73560 | X-ray of knee, 1-2 views | Office | 2023 | 12 | 14 | $1,400 | $261.09 | 18.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 30 | $1,800 | $242.99 | 13.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 43 | 52 | $769.00 | $170.50 | 22.2% |
About Dr. Sang Tae Kim, DO
Dr. Sang Tae Kim, DO is a Family Medicine healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144330762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sang Tae Kim, DO has received a total of $444,684 in payments from pharmaceutical and medical device companies, with $70,280 received in 2024. These payments were reported across 1,970 transactions from 63 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($246,980).
As a Medicare-enrolled provider, Kim has provided services to 4,555 Medicare beneficiaries, totaling 8,773 services with total Medicare billing of $368,582. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Amarillo, TX
- Active Since 08/30/2006
- Last Updated 03/23/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1144330762
Products in Payments
- FARXIGA (Drug) $98,787
- Xofluza (Drug) $75,356
- Auvelity (Drug) $69,272
- Trintellix (Drug) $54,806
- CONTRAVE (Drug) $54,646
- VOQUEZNA (Drug) $17,849
- Repatha (Biological) $15,842
- VRAYLAR (Drug) $14,957
- BYDUREON (Drug) $11,800
- NEXLIZET (Drug) $10,578
- REXULTI (Drug) $1,375
- BEVESPI AEROSPHERE (Drug) $843.56
- TRELEGY ELLIPTA (Drug) $786.31
- TRINTELLIX (Drug) $700.22
- NURTEC ODT (Drug) $645.45
- LEQVIO (Drug) $567.34
- Otezla (Drug) $558.25
- FASENRA (Biological) $542.05
- Kerendia (Drug) $528.08
- BREZTRI (Drug) $484.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Amarillo
Dr. Ron Rankin, M.d, M.D
Family Medicine — Payments: $197,025
Family Medicine $197,025
Dr. Cristiane Ennis, M.d, M.D
Family Medicine — Payments: $97,846
Family Medicine $97,846
Evelyn Sbar, M.d, M.D
Family Medicine — Payments: $51,869
Family Medicine $51,869
Dr. David Brister, M.d, M.D
Family Medicine — Payments: $12,372
Family Medicine $12,372
Dr. Frederick Poage, D.o, D.O
Family Medicine — Payments: $11,752
Family Medicine $11,752
Debra Hammond, Md, MD
Family Medicine — Payments: $9,829
Family Medicine $9,829